Livalo and Thyroid cancer - a phase IV clinical study of FDA data

Summary:

Thyroid cancer is reported only by a few people who take Livalo.

The phase IV clinical study analyzes which people take Livalo and have Thyroid cancer. It is created by eHealthMe based on reports of 7,880 people who have side effects while taking Livalo from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

7,880 people reported to have side effects when taking Livalo.
Among them, 4 people (0.05%) have Thyroid cancer.

What is Livalo?

Livalo has active ingredients of pitavastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 8,136 Livalo users for its effectiveness, alternative drugs and more.

What is Thyroid cancer?

Thyroid cancer is found to be associated with 1,208 drugs and 788 conditions by eHealthMe.

Number of Livalo and Thyroid cancer reports submitted per year:

Gender of people who have Thyroid cancer when taking Livalo *:

female: 100 %
male: 0.0 %

Age of people who have Thyroid cancer when taking Livalo *:

Common drugs people take besides Livalo *:

Common side effects people have besides Thyroid cancer *:

Therapeutic Response Unexpected With Drug Substitution: 3 people, 75.00%
Parathyroid Tumor Benign: 3 people, 75.00%
Enteritis (inflammation of the small intestine): 3 people, 75.00%
Drug Ineffective: 3 people, 75.00%
Colon Cancer: 3 people, 75.00%
Breast Cancer: 3 people, 75.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 50.00%
Laryngeal Nerve Damage: 1 person, 25.00%

Common conditions people have *:

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 75.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Livalo and have Thyroid cancer?

Check whether Thyroid cancer is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Thyroid cancer and when was it recovered:

Thyroid cancer in Livalo

Expand to all the drugs that have ingredients of pitavastatin calcium:

Thyroid cancer and drugs with ingredients of pitavastatin calcium

Alternative drugs to, pros and cons of Livalo:

Livalo (8,136 reports)

Common Livalo side effects:

Muscle aches (muscle pain): 403 reports
Rashes (redness): 393 reports
Diarrhea: 336 reports
Fatigue (feeling of tiredness): 304 reports
Weakness: 283 reports
Headache (pain in head): 271 reports
Dizziness: 266 reports

Browse all side effects of Livalo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thyroid cancer treatments and more:

Thyroid cancer (21,148 reports)

COVID vaccines that are related to Thyroid cancer:

Common drugs associated with Thyroid cancer:

All the drugs that are associated with Thyroid cancer:

Thyroid cancer (1,208 drugs)

Common conditions associated with Thyroid cancer:

Gastroesophageal reflux disease: 2,356 reports
Multiple sclerosis: 765 reports
Rheumatoid arthritis: 572 reports
Type 2 diabetes: 357 reports
High blood pressure: 315 reports

All the conditions that are associated with Thyroid cancer:

Thyroid cancer (788 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pitavastatin calcium (the active ingredients of Livalo) and Livalo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.